文献速递肝病

循环白蛋白-胆红素复合物的分子椭圆率与重症酒精性肝炎患者死亡率相关

Molecular Ellipticity of Circulating Albumin-Bilirubin Complex Associates With Mortality in Patients With Severe Alcoholic Hepatitis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2017-11-16

该横断面研究纳入印度新德里肝胆科学研究所2014年1月至2016年1月收治的265例重症酒精性肝炎(SAH)患者,采用圆二色谱(CD)光谱定量白蛋白-胆红素复合物的分子椭圆率(ME)。ME高于1.84 mdeg预测3个月死亡率的ROC曲线下面积为0.87(95%CI 0.79-0.95),阳性预测值77%,阴性预测值90%。ME与白蛋白结合能力(ABiC)呈负相关(r2>0.7;P<.01)。

要点

  • SAH患者白蛋白-胆红素复合物ME高于酒精性肝硬化组和健康对照组(P<.01)。
  • ME>1.84 mdeg预测SAH患者3个月死亡率:AUC 0.87(95%CI 0.79-0.95),阳性预测值77%,阴性预测值90%。
  • SAH患者ME与ABiC呈负相关(r2>0.7;P<.01),体外实验示胆红素升高可降低ABiC。

核心结论

  • 在SAH横断面研究中,CD光谱测定的白蛋白-胆红素复合物ME与患者结局相关。
  • 白蛋白上胆红素负荷增加可解释白蛋白功能降低。
  • 白蛋白透析清除胆红素可能使SAH患者获益。

研究设计与样本

  • 横断面研究,纳入2014年1月至2016年1月印度新德里肝胆科学研究所肝病科收治的265例SAH患者,随访12个月或至死亡。
  • 发现队列包括30例研究期间存活者和60例未存活者,并与60例酒精性肝硬化患者及30例健康对照比较。
  • 在同一研究所另取150例SAH患者组成的独立队列中验证结果。

主要发现

  • SAH患者胆红素:白蛋白摩尔比高于酒精性肝硬化患者和对照组(P<.05)。
  • SAH患者CD光谱与其他组不同,ME高于其他组(P<.01);ME与MELD评分(含Na和不含Na)及判别函数相关(r2>.3;P<.01)。
  • ME>1.84 mdeg预测SAH患者3个月死亡率:AUC 0.87(95%CI 0.79-0.95),阳性预测值77%,阴性预测值90%。
  • SAH患者ME对3个月死亡率的风险比和一致性指数比MELD评分高10%。
  • SAH患者ME与ABiC呈负相关(r2>0.7;P<.01);体外制备的白蛋白-胆红素复合物中,胆红素水平升高时ABiC显著降低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Hyperbilirubinemia and hypoalbuminemia are features of hepatic dysfunction that associate with disease severity. This is because hepatic insufficiency causes hypoalbuminemia, which indirectly increases the circulating levels of free bilirubin. Circular dichroism (CD) spectroscopy can be used to quantify the molecular ellipticity (ME) of the albumin-bilirubin complex, and might associate with the severity or outcome of severe alcoholic hepatitis (SAH). METHODS: We performed a cross-sectional study of 265 patients with SAH admitted in the Department of Hepatology, Institute of Liver and Biliary Sciences in New Delhi, India from January 2014 through January 2016. Blood samples were collected and patients were followed for 12 months or death. The molar ratios of bilirubin: albumin and albumin-bilirubin complexes were determined for a discovery cohort (30 patients who survived the study period and 60 patients who did not survive) and compared with those of 60 patients with alcoholic cirrhosis and 30 healthy individuals (controls). Optical activities of albumin-bilirubin complexes in blood samples were determined by CD spectroscopy and compared among groups. Findings were validated in a separate cohort of 150 patients with SAH from the same institute. We studied the correlation between ME and albumin binding capacity (ABiC). RESULTS: The molar ratio of bilirubin: albumin was higher in patients with SAH than with alcoholic cirrhosis or controls (P < .05). Patients with SAH had different CD spectra and higher ME than the other groups (P < .01); ME correlated with model for end-stage liver disease score (with and without Na) and discriminant function (r2 > .3; P < .01). ME values above a cut off of 1.84 mdeg predicted 3-month mortality in patients with SAH with an area under receiver operating characteristic curve of 0.87 (95% CI, 0.79-0.95), a 77% positive predictive value, and a 90% negative predictive value. The hazard ratio and concordance index of ME values for 3-month mortality in patients with SAH was 10% higher than the hazard ratio and concordance index of model for end-stage liver disease score. In patients with SAH, there was an inverse correlation between ME and ABiC (r2 > 0.7; P < .01). We observed a significant reduction in ABiC with increasing levels of bilirubin in vitro prepared albumin-bilirubin complex. CONCLUSION: In a cross-sectional study of patients with SAH, we associated ME of the albumin-bilirubin complex, measured by CD spectroscopy, with outcomes of patients with SAH. Increased loading of bilirubin on albumin could explain reduced albumin function. Bilirubin removal by albumin dialysis might benefit patients with SAH.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Das S, Maras JS, Maiwall R, et al. Molecular Ellipticity of Circulating Albumin-Bilirubin Complex Associates With Mortality in Patients With Severe Alcoholic Hepatitis. Clin Gastroenterol Hepatol. 2017. PMID: 29155355. doi:10.1016/j.cgh.2017.11.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。